Makale
Derleme
Uluslararası
2018
Sulfonamide inhibitors: a patent review 2013-present
EXPERT OPINION ON THERAPEUTIC PATENTS
Cilt 28 · Sayı 7 · ss. 541–549 · 01.01.2018
Özet
Introduction: Sulfonamide compounds are significant class of synthetic bacteriostatic antibiotics still which used today for the therapy of bacterial infections and those caused by other microorganisms. They are also known as sulfa drugs and were the main source of therapy against bacterial infections before the introduction of penicillin in 1941. Additionally, The first sulfonamide section is present inmany clinically used drugs such as diuretics, carbonic anhydrase inhibitors and antiepileptics.
Anahtar kelimeler
carbonic anhydrase
DERIVATIVES
Acetylcholinesterase
sulfonamide
BIOLOGICAL EVALUATION
Enzyme inhibitor
Tyrosine kinase
HIV-1 protease
Histone deacetylase 6
protein tyrosine phosphatase 1B
sphingosine kinase
pyrazole kinase
tyrosyl DNA phosphodiesterase
CHRONIC MYELOID-LEUKEMIA
TYROSINE KINASE INHIBITORS
DNA PHOSPHODIESTERASE I
PROTEASE INHIBITORS
PHOSPHATASE 1B
Atıf için künye
Gülçin, İ., & TASLIMI, P. (2018). Sulfonamide inhibitors: a patent review 2013-present. EXPERT OPINION ON THERAPEUTIC PATENTS, 28(7), 541–549. https://doi.org/10.1080/13543776.2018.1487400
BibTeX
@article{gulcin2018-67613,
author = {Gülçin, İlhami and TASLIMI, Parham},
title = {Sulfonamide inhibitors: a patent review 2013-present},
journal = {EXPERT OPINION ON THERAPEUTIC PATENTS},
year = {2018},
volume = {28},
number = {7},
pages = {541--549},
issn = {1354-3776},
doi = {10.1080/13543776.2018.1487400},
url = {https://akademik.atauni.edu.tr/yayinlar/67613-sulfonamide-inhibitors-a-patent-review-2013-present}
}